Castle Biosciences, Inc. CSTL
$20.67
▼ -1.48% 24H
About
Castle Biosciences, Inc. is a molecular diagnostics company that develops and provides innovative gene expression profile tests to guide patient care in oncology and related fields. Its portfolio includes DecisionDx-Melanoma, a risk stratification test predicting metastasis risk in cutaneous melanoma patients; Decision…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees942
TickerCSTL
Statistics
Market Cap$626.2M
Revenue (TTM)$344.2M
Net Income-$24.2M
Net Margin-7.0%
EPS$-0.83
P/E30.48
P/S1.85
P/B1.36
EV/EBITDA-21.95
ROE-2.8%
Dividend Yield—
Price$20.67
Data: Twelve Data · Revenue = mcap / P/S